The up-regulation of CCL19 was also observed in patients with primary and secondary SS compared to another autoimmune disorder or control, and was considered to contribute to the leukocyte microenvironmental homing in MSG from SS patients (56). This evidence concerns the gene CCL19 and synovial sarcoma.